Lars Bardtrum, MSc

Novo Nordisk A/S
BioStat degludec
Papers:
OR49-1 Rate of Recurrent Confirmed Hypoglycemia with Insulin Degludec vs. Insulin Glargine in Patients with Type 2 Diabetes